Cinnal-f is the brand name of follitropin alfa. Each Cinnal-f pre-filled pen contains 450 or 900 IU of follitropin alfa as ready-to-use solution. Cinnal-f pen is available in a pack containing 1 sterile pre-filled pen and patient information leaﬂet. Also, the vial of Cinnal-f is manufactured which has 75 IU of follitropin alfa. Cinnal-f vial is available in a pack containing a sterile vial of lyophilized powder, a sterile vial of WFI and patient information leaﬂet.
Do not use Cinnal-f if you:
Call your healthcare provider at once if you have abdominal pain or enlargement, diarrhea, nausea, vomiting, oliguria, and dyspnea.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Your healthcare provider will prescribe the dose that is right for you.
Do not use Cinnal-f if you are pregnant.
It is not known whether this drug is excreted in human milk. The decision should be made by your healthcare provider whether to discontinue nursing or to discontinue the drug.
If you miss a dose of Cinnal-f, contact your healthcare provider right away.
If you think there has been an overdose, call your poison control center or get medical care right away.
Cinnal-f is injected under the skin (subcutaneous). Read the detailed Instructions for Use.
Like all medicines, Cinnal-f can cause side effects, although not everybody gets them. Tell your healthcare provider or get medical help right away if you have any of the following signs or symptoms:
Ovarian cyst, headache, acne vulgaris, abdominal pain, nausea, mastalgia (in men), upper respiratory tract infection, and injection site reaction.
These are not all the possible side effects of Cinnal-f.